BEIJING, March 16 (Xinhua) -- Alibaba Health Information Technology Limited (AliHealth, 00241.HK), the healthcare flagship of Alibaba Group, has taken multiple measures to help people amid the outbreak of the novel coronavirus pneumonia (COVID-2019).
On January 24, the company launched free Internet-backed consultation and diagnosis services in the apps of Alipay and Taobao to relieve the pressure of frontline clinics.
Recently, it unveiled an online medical consultation feature for overseas Chinese in partnership with Alipay. Nearly 100 Chinese embassies and consulates abroad have recommended the service feature, reported the Xinhua-run cs.com.
The healthcare solution provider has also worked with more than 50 leading pharmaceutical companies in the world and businesses across China to ensure drug supply, and opened special drug delivery channels to provide life-saving drugs for the 13 million patients with chronic diseases in central China's Hubei province, the epicenter of the epidemic.
Internet technology-driven medical and healthcare services have greatly shored up the battle against COVID-2019 and production resumption. Against this backdrop, AliHealth said it would speed up making innovation to help boost the construction of digital infrastructure for the medical and healthcare industries in China. (Edited by Su Dan, silviasu07@163.com)
A single purchase
